RESULTS OF IMMUNOHISTOCHEMICAL STUDY OF THE THYROID GLAND IN GRAVES' DISEASE
Abstract
Diffuse toxic goiter is a genetically determined autoimmune disease with a congenital defect of the immune system. With diffuse toxic goiter, the secretion of the thyroid hormones triiodothyronine (T3) and thyroxine (T4) increases, which often leads to thyrotoxicosis.
References
Abramov, N.A., Fadeev, V.V. Conservative treatment of Graves' disease: principles, markers of relapse and remission // Problems of endocrinology. – 2005. – No. 6. - pp. 44-45.
Balabolkin, M.I. Modern approaches to the treatment of diffuse toxic goiter // Therapist. arch. – 1995. – No. 10. – P.15-18.
Valdina, E.A. Diseases of the thyroid gland. – St. Petersburg: Peter, 2001. – 368 p.
Kandror, V.I. Mechanisms of development of Graves' disease and the action of thyroid hormones // Clinical experimental thyroidology. – 2008. – No. 4. – P.26-34.
Shaposhnikov, V.M. Morphofunctional features of the thyroid gland in patients with diffuse toxic goiter // Klin. endocrinology. – 1991. – No. 1. – P.8-9. 300 Biodiversity, bioresources, biotechnology issues and public health in the North Caucasus region of Stavropol, 2019
